Cargando…

Adaptation of Mitochondrial Substrate Flux in a Mouse Model of Nonalcoholic Fatty Liver Disease

Maladaptation of mitochondrial oxidative flux seems to be a considerable feature of nonalcoholic fatty liver disease (NAFLD). The aim of this work was to induce NAFLD in mice fed a Western-style diet (WD) and to evaluate liver mitochondrial functions. Experiments were performed on male C57BL/6J mice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staňková, Pavla, Kučera, Otto, Peterová, Eva, Lotková, Halka, Maseko, Tumisang Edward, Nožičková, Kateřina, Červinková, Zuzana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036817/ https://www.ncbi.nlm.nih.gov/pubmed/32046101 http://dx.doi.org/10.3390/ijms21031101

Ejemplares similares

Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD Model
por: Staňková, Pavla, et al.
Publicado: (2021)

In Vitro Toxicity of Epigallocatechin Gallate in Rat Liver Mitochondria and Hepatocytes
por: Kucera, Otto, et al.
Publicado: (2015)

The Effect of tert-Butyl Hydroperoxide-Induced Oxidative Stress on Lean and Steatotic Rat Hepatocytes In Vitro
por: Kučera, Otto, et al.
Publicado: (2014)

Epigallocatechin Gallate Does Not Accelerate the Early Phase of Liver Regeneration After Partial Hepatectomy in Rats
por: Mezera, Vojtěch, et al.
Publicado: (2013)

The Mitochondrial Permeability Transition Pore—Current Knowledge of Its Structure, Function, and Regulation, and Optimized Methods for Evaluating Its Functional State
por: Endlicher, René, et al.
Publicado: (2023)

Effects of Epigallocatechin Gallate on Tert-Butyl Hydroperoxide-Induced Mitochondrial Dysfunction in Rat Liver Mitochondria and Hepatocytes
por: Mezera, Vojtech, et al.
Publicado: (2016)

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
por: Liu, Cong, et al.
Publicado: (2018)

Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
por: Hirsova, Petra, et al.
Publicado: (2020)

The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease
por: Chimienti, Guglielmina, et al.
Publicado: (2021)

Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease
por: Li, Ruibing, et al.
Publicado: (2020)

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022)

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach
por: Nuño-Lámbarri, Natalia, et al.
Publicado: (2016)

Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice
por: Nassir, Fatiha, et al.
Publicado: (2018)

Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis
por: Zeng, Chuanfei, et al.
Publicado: (2022)

Cadmium promotes nonalcoholic fatty liver disease by inhibiting intercellular mitochondrial transfer
por: Sun, Jian, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Biological autoluminescence for assessing oxidative processes in yeast cell cultures
por: Vahalová, Petra, et al.
Publicado: (2021)

Increased Nitroxidative Stress Promotes Mitochondrial Dysfunction in Alcoholic and Nonalcoholic Fatty Liver Disease
por: Song, Byoung-Joon, et al.
Publicado: (2013)

Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease
por: Chang, Eunha, et al.
Publicado: (2022)

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
por: Chen, Yifei, et al.
Publicado: (2022)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial Biogenesis
por: Han, Hao, et al.
Publicado: (2019)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis
por: Lastuvkova, Hana, et al.
Publicado: (2023)

Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress
por: Quinn, Connor, et al.
Publicado: (2022)

The canonical equation of adaptive dynamics for life histories: from fitness-returns to selection gradients and Pontryagin’s maximum principle
por: Metz, Johan A. Jacob, et al.
Publicado: (2015)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2020)

Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease's Statin Therapy in Men
por: Hadzi-Petrushev, Nikola, et al.
Publicado: (2018)

The Reducing Hospital Costs through Horizontal Integration
por: Staňková, Pavla, et al.
Publicado: (2019)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dras8hn32gbf52klui3d3gjkod